XFOR Competitors & Alternatives
Compare X4 Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
XFOR
Main Stock$2.83
Tradestie Score
50
Market Cap
$81.27M
P/E Ratio
2.0
Revenue Growth
3.5%
Analyst Upside
+309.9%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.24
|
$307.12M | - | 42 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.18
|
$304.12M | - | 54 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.12
|
$297.23M | - | 55 | Compare |
|
OMER
Omeros Corporation
|
$18.61
|
$281.75M | 11.2 | 54 | Compare |
|
DBVT
DBV Technologies S.A.
|
$10.55
|
$275.54M | - | 42 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.50
|
$275.13M | - | 41 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.69
|
$269.08M | 0.1 | 72 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$9.51
|
$265.45M | 19.3 | 53 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$25.65
|
$256.54M | - | 46 | Compare |
More XFOR Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry